News

Published on 26 Jul 2022 on Zacks via Yahoo Finance

Celanese (CE) to Report Q2 Earnings: What's in the Offing?


Article preview image

Celanese Corporation CE is set to release second-quarter 2022 results, after market close on Jul 28. Benefits from productivity actions, project investment, higher demand and strategic acquisitions are likely to get reflected in second-quarter performance. However, the company is likely to have faced headwinds from higher input costs.

The leading chemical and specialty materials maker beat the Zacks Consensus Estimate for earnings in three of the last four quarters while missed once. It has a trailing four-quarter earnings surprise of roughly 8.7%, on average. The company delivered an earnings surprise of around 23.4% in the last reported quarter.

Celanese’s shares have declined 25.2% in the past year compared with a 19.4% fall of the industry.

NYSE.CE price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
IFG Advisory LLC Boosts Holdings in Celanese Co. (NYSE:CE)

IFG Advisory LLC increased its holdings in Celanese Co. (NYSE:CE – Free Report) by 80.6% in the 4...

ETF DAILY NEWS 15 hours ago

Celanese (CE) Gets ISCC-Certified for Low Carbon CCU Methanol

Celanese Corporation CE recently announced that the International Sustainability and Carbon Certi...

Zacks via Yahoo Finance 25 Mar 2024

Eastman Chemical (EMN) Gains on Cost Cuts and Innovation

Eastman Chemical Company EMN is benefiting from its innovation-driven growth model, operational e...

Zacks via Yahoo Finance 25 Mar 2024

Wells Fargo raises Celanese stock target to $195 on positive outlook

Wells Fargo raises Celanese stock target to $195 on positive outlook

Investing.com 22 Mar 2024

Senior Vice President of Engineered Materials of Celanese Thomas Kelly Buys 2.6% More Shares

Investors who take an interest in Celanese Corporation (NYSE:CE) should definitely note that the ...

Simply Wall St. via Yahoo Finance 22 Mar 2024

Celanese (CE) and Secarna Partner for Antisense Therapies

Celanese Corporation CE and Secarna Pharmaceuticals GmbH & Co. KG recently established a research...

Zacks via Yahoo Finance 22 Mar 2024

Here's Why You Should Hold Onto Celanese (CE) Stock For Now

Celanese Corporation CE is benefiting from its cost and productivity actions, investments in high...

Zacks via Yahoo Finance 21 Mar 2024

Celanese and Secarna partner on drug delivery technology By Investing.com

DALLAS & MARTINSRIED, Germany - Celanese Corporation (NYSE: NYSE:CE), a global specialty material...

Investing.com 20 Mar 2024

Celanese Co. (NYSE:CE) Shares Purchased by Massmutual Trust Co. FSB ADV

Massmutual Trust Co. FSB ADV increased its holdings in shares of Celanese Co. (NYSE:CE – Free...

ETF DAILY NEWS 19 Mar 2024

Deutsche Bank AG Has $23.49 Million Position in Celanese Co. (NYSE:CE)

The fund owned 187,134 shares of the basic materials company’s stock after purchasing an addition...

ETF DAILY NEWS 19 Mar 2024